Sesen Bio Inc (NASDAQ:SESN)
| 0.4093 Delayed Data As of Sep 23 |  -0.0208 / -4.84%Today’s Change | 0.37 Today|||52-Week Range 1.47 | -49.78% Year-to-Date |
Latest SESN News | Press Releases
Today’s Trading
| Previous close | 0.43 |
| Today’s open | 0.43 |
| Day’s range | 0.40 - 0.43 |
| Volume | 26,540 |
| Average volume (3 months) | 3,197,162 |
| Market cap | $81.6M |
Data as of 3:52pm ET, 09/23/2022
Growth & Valuation
| Earnings growth (last year) | +99.06% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +136.24% |
| P/E ratio | 1.2 |
| Price/Sales | 5.60 |
| Price/Book | 0.48 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ASMBAssembly Biosciences... | -0.09 | -5.03% |
| ---- | ||
| SPPISpectrum Pharmaceuti... | 0.00 | 0.00% |
| LIFEaTyr Pharma Inc | +0.02 | +0.72% |
Data as of 4:00pm ET, 09/23/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $26.5M |
| Annual profit (last year) | -$336.0K |
| Net profit margin | -1.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
